Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Lactoferrin and Lysozyme Oral Solution in Pediatric Rotavirus Diarrhea
CTR20212251Phase 2Completed
- Sponsor
- Healthgen Biotech
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human lactoferrin + lysozyme in rotaviral diarrhea, acute diarrhea, sponsored by Healthgen Biotech. Started Sep 2021; status: completed.
02
Drugs
recombinant human lactoferrin + lysozyme
03
Conditions
rotaviral diarrheaacute diarrhea
Beyond the preview
Go deeper on CTR20212251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212251.